Clarification – TruScreen Interim Results – SalesTimeline

NZX and Media Release 14 December, 2017 NZX Limited WELLINGTON TRUSCREEN INTERIM RESULTS TO 30 SEPTEMBER 2017 Clarification Timing of sales for Financial Year Ending 31 March, 2018 TruScreen wishes to clarify the statement made in its results announcement today regarding the timing of the increase in sales. The reference to the 'final quarter of FY18' refers to the final quarter of the financial year ending 31 March, 2018. That is, January to March, 2018. ENDS For more information visit www.truscreen.com or contact: Martin Dillon TruScreen Chief Executive Officer Email: martindillon@truscreen.com Media Liaison Jackie Ellis Email: jackie@ellisandco.co.nz Phone: +64 27 246 2505 About TruScreen: TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection End CA:00311980 For:TRU Type:HALFYR Time:2017-12-14 15:36:33